Rule 3a-8 under the Investment Company Act; Certain Research and Development Companies

ICR 202305-3235-028

OMB: 3235-0574

Federal Form Document

Forms and Documents
Document
Name
Status
Supplementary Document
2023-08-14
Supplementary Document
2023-08-14
Supporting Statement A
2023-05-30
IC Document Collections
ICR Details
3235-0574 202305-3235-028
Received in OIRA 202008-3235-006
SEC IM 270-516
Rule 3a-8 under the Investment Company Act; Certain Research and Development Companies
Extension without change of a currently approved collection   No
Regular 08/14/2023
  Requested Previously Approved
36 Months From Approved 01/31/2024
1 1
1 1
0 0

The SEC requires this collection of information to ensure involvement of the company's board of directors in determining a research and development company's status under the Investment Company Act of 1940 and as evidence of the company's primary business activities. The respondents will be research and development companies relying on the rule.

US Code: 15 USC 80a Name of Law: Investment Company Act of 1940
  
None

Not associated with rulemaking

  88 FR 36620 06/05/2023
88 FR 55088 08/14/2023
No

1
IC Title Form No. Form Name
Rule 3a-8 under the Investment Company Act, Certain Research and Development Companies

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 1 1 0 0 0 0
Annual Time Burden (Hours) 1 1 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$0
No
    No
    No
No
No
No
No
Y. Rachel Kuo 202 551-3589

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
08/14/2023


© 2024 OMB.report | Privacy Policy